TABLE 2.
HIV testing events among blacks† | Newly identified HIV-positive blacks | Linked to HIV medical care within any timeframe | Linked to HIV medical care within 90 days | Referred to HIV partner services | Interviewed for HIV partner services | Referred to HIV prevention services | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
||||||||
Characteristic | No. | (%) | No. | (%) | No. | (%) | No. | (%) | No. | (%) | No. | (%) | No. | (%) |
Age group (yrs) | ||||||||||||||
13–19 | 143,797 | (9.5) | 399 | (0.28) | 216 | (54.1) | 179 | (44.9) | 287 | (71.9) | 191 | (47.9) | 218 | (54.6) |
20–29 | 639,706 | (42.5) | 3,989 | (0.62) | 2,142 | (53.7) | 1,783 | (44.7) | 2,744 | (68.8) | 1,852 | (46.4) | 2,207 | (55.3) |
30–39 | 308,182 | (20.5) | 1,935 | (0.63) | 1,055 | (54.5) | 873 | (45.1) | 1,252 | (64.7) | 903 | (46.7) | 1,011 | (52.2) |
40–49 | 198,277 | (13.2) | 1,530 | (0.77) | 777 | (50.8) | 647 | (42.3) | 916 | (59.9) | 668 | (43.7) | 725 | (47.4) |
≥50 | 207,908 | (13.8) | 1,488 | (0.72) | 795 | (53.4) | 653 | (43.9) | 899 | (60.4) | 663 | (44.6) | 765 | (51.4) |
Sex | ||||||||||||||
Male | 706,148 | (46.9) | 7,224 | (1.02) | 3,858 | (53.4) | 3,200 | (44.3) | 4,787 | (66.3) | 3,333 | (46.1) | 3,927 | (54.4) |
Female | 793,894 | (52.7) | 2,196 | (0.28) | 1,194 | (54.4) | 1,001 | (45.6) | 1,405 | (64.0) | 1,049 | (47.8) | 1,132 | (51.5) |
Region | ||||||||||||||
Northeast | 245,322 | (16.3) | 1,294 | (0.53) | 844 | (65.2) | 746 | (57.7) | 947 | (73.2) | 681 | (52.6) | 977 | (75.5) |
Midwest | 192,506 | (12.8) | 956 | (0.50) | 369 | (38.6) | 329 | (34.4) | 610 | (63.8) | 356 | (37.2) | 505 | (52.8) |
South | 995,531 | (66.1) | 6,787 | (0.68) | 3,562 | (52.5) | 2,867 | (42.2) | 4,308 | (63.5) | 3,057 | (45.0) | 3,337 | (49.2) |
West | 68,679 | (4.6) | 530 | (0.77) | 343 | (64.7) | 316 | (59.6) | 430 | (81.1) | 344 | (64.9) | 305 | (57.5) |
U.S. dependent areas | 3,978 | (2.6) | 4 | (0.10) | 3 | (75.0) | 3 | (75.0) | 3 | (75.0) | 3 | (75.0) | 2 | (50.0) |
Target population § | ||||||||||||||
Men who have sex with men | 37,222 | (8.8) | 3,570 | (9.6) | 2171 | (60.8) | 1,970 | (55.2) | 2,821 | (79.0) | 2,008 | (56.2) | 2,417 | (67.7) |
Heterosexual males | 119,403 | (28.1) | 1,793 | (1.5) | 914 | (51.0) | 814 | (45.4) | 1,270 | (70.8) | 915 | (51.0) | 966 | (53.9) |
Heterosexual females | 136,205 | (32.1) | 1,508 | (1.1) | 870 | (57.7) | 802 | (53.2) | 1,126 | (74.7) | 844 | (56.0) | 892 | (59.2) |
Total | 1,506,016 | 9,571 | (0.64) | 5,121 | (53.5) | 4,261 | (44.5) | 6,298 | (65.8) | 4,441 | (46.4) | 5,126 | (53.6) |
Abbreviation: HIV = human immunodeficiency virus.
Source: National HIV Prevention Program Monitoring and Evaluation system.
The denominator for the percentage for newly identified HIV-positive persons is HIV testing events. The denominator for the percentages of all other columns is newly identified HIV-positive persons.
The percentages for HIV testing events are column percentages. For target populations, the denominator is 424,497, and for all other client characteristics, the denominator is 1,506,016.
Not required for persons who test negative in health care settings. Data to identify target populations are required for all testing events conducted in non–health care settings but are only required for HIV-positive persons from health care settings. Therefore, for target populations, HIV testing events and newly identified HIV-positive persons represent data from non–health care settings but only positive testing events from health care settings (N = 424,497). Other target populations and missing data accounted for 31.0% of HIV testing events (transgender = 0.4%, persons who inject drugs = 1.1%, persons not reporting sex with male or female or injection drug use [i.e., no risk behavior] = 9.9%, and missing = 19.6%).